Cardiac masses are rare, but remain an important component of cardio-oncology practice.
These include benign tumors, malignant tumors (primary and secondary) and tumor-like …

Cardiovascular magnetic resonance (CMR) is considered the gold standard imaging
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …

In recent years, cardiovascular diseases (CVDs) have become one of the leading causes of
mortality globally. At early stages, CVDs appear with minor symptoms and progressively get …

Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in
cancer survivors. This review identifies features that could help guide decisions about the …

Cardiotoxicity may present as (pulmonary) hypertension, acute and chronic coronary
syndromes, venous thromboembolism, cardiomyopathies/heart failure, arrhythmia, valvular …

Primary cardiac tumors (PCTs) are rare, with benign PCTs being relatively common in
approximately 75% of all PCTs. Benign PCTs are usually asymptomatic, and they are found …

Cancer mortality has improved due to earlier detection via screening, as well as due to novel
cancer therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitions …

Abstract Coronavirus disease 2019 (COVID‐19) has emerged as a global pandemic and
public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically …

Breast cancer survival is significantly improved over the past decades due to major
improvements in anti-tumor therapies and the implementation of regular screening, which …

Cancer and cardiovascular disease (CVD) are the leading cause of mortality worldwide, and
breast cancer (BC) the most common malignancy affecting women worldwide. Radiotherapy …